Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction is a research paper published in Frontiers in Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL144661
NIAID NIH HHS
Grant: R01 AI117408
NHLBI NIH HHS
Grant: R01 HL151348
National Institutes of Health
Grant: 5R01HL151348-04
Development of AAV vectors for CF therapy
National Institutes of Health
Grant: 1R01HL144661-01
Optimization of AAV vector to deliver FVa for hemophilia with inhibitors
National Institutes of Health
Grant: 5R01AI117408-04
Enhance AAV Liver Transduction with Capsid Immune Evasion
FWCI
0.30
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals